Mestastop® Solutions

Mestastop® Solutions

Biotechnology Research

Marlton, New Jersey 2,332 followers

Stopping Metastasis, giving life a second chance

About us

Cancer can be broken down into four parts; mainly initiation, progression, immunosuppression, and finally metastasis, leading to death. Initiation and progression happen due to genetic reasons along with the interplay of the tumor microenvironment, whereas immunosuppression is the inefficiency of the body’s immune system to recognize and destroy cancer cells. Metastasis is the movement of tumor cells through the blood and the formation of multiple tumors into different secondary sites of the body. Metastasis is responsible for almost 90% of cancer deaths. Unfortunately, though cancer treatment has advanced with targeted therapy and immunotherapy, there is still a huge gap as none of them addresses metastasis. One of the main reasons for these are the challenges faced in advancing a molecule targeting metastasis; from suitable In vitro models to the perfect animal model that will closely resemble the biology without alleviating cost and timelines. Mestastop aims to provide a solution for such challenges with their unique proprietary platforms, METAssay, METSCAN, and METVivo.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Marlton, New Jersey
Type
Privately Held
Founded
2018
Specialties
biotechnologyresearch, metastasis, cancer, and drugrepurposing

Locations

Employees at Mestastop® Solutions

Updates

Similar pages

Browse jobs

Funding

Mestastop® Solutions 3 total rounds

Last Round

Seed

US$ 541.4K

See more info on crunchbase